To examine the effects of a 1-year exercise intervention on sex hormone levels in postmenopausal women and whether any effects are mediated by changes in body fat composition.
INTRODUCTION
Most of the established risk factors for breast cancer, such as family history of the disease, early age at menarche, late age at menopause, late age at first childbirth, or nulliparity, are not, or not easily, amenable to intervention. Physical activity, however, is a modifiable lifestyle characteristic that has been associated with decreased breast cancer risk.
1,2 The causal mechanism is not clear, and it is unknown whether increasing physical activity at later age still reduces breast cancer risk. Sex hormones are mainly proposed as mediators for the observed association between exercise and breast cancer. 3, 4 The evidence that estrogens contribute to breast cancer risk is strong and widely accepted. A reanalysis of nine prospective studies showed that a relatively high level of endogenous estrogens in postmenopausal women is associated with a two-to three-fold increased risk of breast cancer. 5 Postmenopausal women with higher androgen levels also have increased risk. 5, 6 In cross-sectional studies, a low level of physical activity has been associated with 15% to 25% higher serum concentrations of estradiol, estrone, and androgens in postmenopausal women after adjustment for body mass index (BMI) [7] [8] [9] [10] ; however, these results have not been observed in all studies.
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This association might be partly explained both directly and also indirectly through accumulation of adipose tissue. 12, 13 After menopause, adipose tissue is the primary source of estrogen production as a result of peripheral conversion from androgens by aromatase. 14, 15 Compared with normal-weight postmenopausal women, obese postmenopausal women have higher blood concentration of estrogens and androgens and lower concentration of sex hormone-binding globulin (SHBG). 10, 16, 17 Regular exercise represents an approach to regulate energy balance and to prevent accumulation of adipose reserves and consequently influences the production of estrogens. So far, one study has been published assessing the effects of exercise interventions on sex hormones in US women.
This randomized intervention study of 12-month moderate-intensity exercise in sedentary, overweight, postmenopausal women resulted in significant decreases in serum estrogens and androgens, but only in women who lost body fat. To assess this relationship in Dutch women who differ from US women in terms of weight and physical activity level, we designed the Sex Hormones and Physical Exercise (SHAPE) study (trial registration No. NCT00359060). We hypothesized that exercise would lower sex steroid levels mainly as a result of changes in total body fat.
METHODS
The SHAPE study is a randomized controlled trial examining the effects of a 1-year moderate-to vigorous-intensity exercise program on sex hormone levels among sedentary postmenopausal women. The study was approved by the ethical committee of the University Medical Center Utrecht, and written informed consent was obtained from each participant. The design of the SHAPE study has been described previously. 20 In short, we included 189 healthy sedentary postmenopausal women age 50 to 69 years. These women were recruited through a random selection of the female inhabitants of several municipalities in the Netherlands. Postmenopausal status was defined as having no menses for at least 1 year, 21 and sedentary was defined as engaging less than 2 hours per week in moderate sport and recreational activities and not adherent to the international physical activity recommendation. 19 Exclusion criteria included use of hormone replacement therapy, smoking, BMI less than 22 kg/m 2 , corticosteroid use, cancer in the past 5 years, and diabetes mellitus or other endocrine-related diseases. Eligible women were enrolled by a study nurse. Random assignment was concealed and blocked on two categories of waist circumference (Ͻ and Ն 92 cm; cutoff level was based on the median value reported in comparable women).
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Intervention
Women in the intervention group participated in a combined aerobic and strength training program over a period of 12 months. The program was organized in a way to induce fat loss and to reach a training stimulus in each person. The exercise prescription consisted of 1-hour supervised group sessions twice a week and an individual session of 30 minutes once a week. Further details have been described elsewhere. 20 Control participants were requested to retain their habitual exercise pattern. Exercisers and controls were asked to maintain their usual diet.
Outcome Measurements
The study participants visited the medical research unit at baseline and after 4 and 12 months. A study nurse performed measurements and collected information by questionnaires. Each visit, blood samples were taken. In addition, anthropometric measurements and dual-energy x-ray absorptiometry to measure body fat were performed. Also, medication use was assessed at each visit. 
Blood Samples
Blood samples were drawn between 9:00 and 11:00 AM after an overnight fast and stored at Ϫ70°C. Serum concentrations of estradiol (total and free), estrone, estrone sulfate, testosterone (total and free), androstenedione, and SHBG were determined by laboratory technicians blinded to intervention status. All samples of one individual were analyzed in the same batch. Commercially available double-antibody radioimmunoassay kits were used (Diagnostic System Laboratories, Webster, TX, and ZenTech, Angleur, Belgium) for estradiol (DSL-4800), estrone (DSL-8700), estrone sulfate (DSL-5400), testosterone (DSL-4100), androstenedione (DSL-4200), and SHBG (IRMA CT). Kits for estrone, androstenedione, and testosterone showed a high relative validity in terms of ranking postmenopausal women. 23 The mean intra-assay coefficients of variation were as follows: 10.0% (estradiol), 14.0% (estrone), 6.4% (estrone sulfate), 9.8% (testosterone), 5.3% (androstenedione), and 12.8% (SHBG). Free estradiol and free testosterone were calculated using the measured values for estradiol or testosterone, SHBG, and an assumed constant for albumin. 24 For SHBG, estrone, and estrone sulfate, some women had undetectable levels at one of their visits (Ͻ 0.26 nmol/L, Ͻ 1.2 pg/mL, and Ͻ 0.01 ng/mL, respectively). At baseline, four women had undetectable estrone levels. At 4 months, one woman had undetectable SHBG levels, and two women had undetectable estrone levels. At 12 months, we found undetectable levels for one woman for SHBG, for three women for estrone, and for one woman for estrone sulfate. For the statistical analyses, the levels of these women were Abbreviations: SD, standard deviation; MET, metabolic equivalent.
‫ء‬
Differences between groups were analyzed with the following tests: t test for normal distributed continuous variables, Mann-Whitney U test for non-normally distributed continuous variables, and 2 test for binomial variables. †Nutritional information of one woman is missing in the intervention group. ‡MET hours per week spent on at least moderate-intensity (4 MET) activities. This was calculated using information from the Modified Baecke Questionnaire. imputed at the lowest detectable level. Although SHBG is technically not a hormone, for reasons of convenience, it will be referred to as such.
Physical Activity and Energy Intake
Habitual exercise was measured by the validated Modified Baecke Questionnaire at baseline and 12 months. 25, 26 We calculated the metabolic equivalent (MET) hours per week spent on at least moderate-intensity activities by coding the sports and leisure time activities reported in this questionnaire according to the Ainsworth Compendium of Physical Activities. 27, 28 Moderate-intensity activities included all sports and leisure time activities of at least 4 MET based on the Dutch standard, which implies that moderate activities lie between 4 and 6.5 MET. 29 At baseline and 12 months, energy intake was measured by a food frequency questionnaire assessing dietary habits in the past month.
30,31 All completed questionnaires were checked by a dietician.
Statistical Analysis
We calculated that 90 participants per study arm were required to detect an intervention effect of 5.5 pg/mL estrone level with 90% power, including a dropout rate of 30%. Because all hormones showed skewed distributions, log-transformed values were used for data analyses. The primary trial analysis was performed according to the intent-to-treat principle. Between-group differences of sex hormone levels were analyzed with generalized estimating equations (GEEs). This longitudinal data analysis technique is suitable to investigate the course over time of the outcome variable and to compare this overall effect between study arms. In all models, the outcome variable (ie, one of the hormones measured at 0, 4, and 12 months) was analyzed as a dependent variable using study group as key independent variable adjusted for the baseline hormone measurement. Adjustment for baseline leads to equal starting points for both groups, and therefore, the intervention effect is presented NOTE. Hormone concentrations were non-normally distributed, and therefore, all hormone values were log transformed. Presented are the geometric means of the hormones. Abbreviations: SHBG, sex hormone-binding globulin; MET, metabolic equivalent; NA, not applicable. *The ␤ coefficient (and P value) represents the overall intervention effect on hormone change over time (adjusted for baseline) and was derived from a generalized estimating equation (GEE) model (coefficient on study group). Because the GEE models were based on log-transformed hormone data, the presented ␤ is the antilogarithm of the original ␤. Therefore, the antilogarithm of the ␤ is a ratio that indicates whether the hormone level is, on average, higher in the intervention group compared with controls (␤ Ͼ 1) or lower (␤ Ͻ 1; eg, ␤ ϭ 0.9 indicates that the hormone level in the intervention group is on average 10% lower in the intervention group compared with the control group).
†Mean between-group difference (95% CI) in percent body fat (intervention -control).
‡MET hours per week spent on at least moderate-intensity (4 MET) activities. §CI of this median difference was calculated using bootstrapping techniques.
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by the coefficient on study group. The group-time interaction provides information about whether the observed effect is stronger at the beginning or at the end of the study. 32 Because the GEE models were based on log-transformed hormone data, we presented the antilogarithm of the original ␤ coefficient in the tables. The antilogarithm of the ␤ is a ratio that indicates whether the hormone level is, on average, higher in the intervention group compared with controls (␤ Ͼ 1) or lower (␤ Ͻ 1; eg, ␤ ϭ 0.9 indicates that the hormone level in the intervention group is, on average, 10% lower in the intervention group compared with controls).
To investigate the association between change in body fat (independent variable) and change in sex hormone levels (dependent variable), we also performed GEE analyses. Furthermore, we analyzed the intervention effect within the subgroup of women who lost more than 2% body fat. We chose this cutoff point to compare results with the study of McTiernan et al. 33, 34 This study observed significant declines in sex hormone levels for women who lost more than 2% body fat. Additionally, we conducted GEE analyses with change in body fat as a covariate in the models. If body fat is an intermediate factor in the relation between physical activity and sex hormone levels, the intervention effect should attenuate when adjusting for change in body fat.
We also performed a per-protocol analysis by excluding participants who were not compliant with the study protocol. Exercisers were considered not compliant if they missed 30% or more of all group sessions or participated in a formal weight loss program. Noncompliance in control women was considered as having started an exercise program or a formal weight loss program.
RESULTS
A total of 189 women were randomly allocated to either the intervention (n ϭ 96) or control group (n ϭ 93; Fig 1) . At baseline, women in both groups were comparable with respect to age, alcohol use, fitness level, and androgen concentrations (Tables 1 and 2 ). However, despite block random assignment, baseline differences for several characteristics were observed, including education level, body fat, BMI, and estradiol levels (all higher for the control group, but only significant for education level).
The number of dropouts in the SHAPE study was low (n ϭ 6; 3.2%) and included one woman in the intervention group and five women in the control group. The number of participants (intervention and control groups) who did not comply with the study protocol was 46 (24.3%). Thirty-five participants (36.5%) in the intervention group missed 30% or more of all group sessions, and 11 participants (11.8%) in the control group started exercise or a weight loss program. Adverse events as a result of the exercise program were not reported. Hormone measurements were available for all women at baseline, for 181 women (95.8%) at 4 months, and 182 women (96.3%) at 12 months.
Self-reported level of moderate physical activity was higher at the end of the study, both for controls and exercisers. However, the activity level increased more in the intervention group (median: from 4.9 to 19.8 MET h/wk) than in controls (median: from 4.3 to 5.8 MET h/wk), and the difference between groups is significant.
Furthermore, the intervention resulted in a significant higher loss of percent body fat compared with controls (⌬ -0.43, ie, the mean percent body fat in the intervention group minus the mean percent body fat in the control group adjusted for baseline in the GEE analysis; Table 2 ). Also, the proportion of women who lost more than 2% fat was somewhat higher in the intervention group versus the control group (42% v 34%, respectively; P ϭ .27).
Estrogens
The intervention group compared with controls showed, on average, larger declines in levels of estradiol, estrone, and estrone sulfate (␤ range, 0.97 to 0.99), but these effects were not significant. The results on free estradiol were null (Table 2 ). In addition, among women who lost more than 2% body fat, declines in all estrogens were not significantly different between exercisers and controls (Table 3) . Adjustment for change in body fat (total study population) attenuated the ␤ coefficients in the GEE analyses (Table 4) . Furthermore, changes in body fat were significantly (positively) associated with changes in estrogen levels (Table 5) ; that is, fat loss resulted in a decline of estrogen levels. Per-protocol analysis showed similar results for the changes in estrogen levels in both groups (data not shown).
Androgens
On average, testosterone (free and total) and androstenedione showed larger declines in the intervention group compared with controls (␤ range, 0.97 to 0.99), although these results were not significant (Table 2 ). In women who lost more than 2% body fat, the androgen level was significantly more decreased in exercisers than in controls (Table 3) . For free and total testosterone, the interaction with time was significant, indicating that the difference between the intervention and control groups among women who lost body fat was only present at 4 months. Adjustment for change in body fat (total study population) attenuated the intervention effect on testosterone (free and total; Table 4). Change in body fat was positively, but not significantly, associated with changes in androgen levels (Table 5) .
Per-protocol analysis showed similar results for the changes in free testosterone and androstenedione (data not shown). For testosterone, however, this analysis showed a significant decline in exercisers compared with controls, which occurred mainly in the first 4 months (exercisers: Ϫ8.4%; controls: ϩ1.7%).
SHBG
During the study, SHBG levels were, on average, 2% lower in the intervention group compared with controls (␤ ϭ 0.98), although this was not significant ( Table 2 ). The per-protocol analysis showed similar results (data not shown). In women who lost more than 2% body fat, SHBG levels were, on average, 5% lower in the intervention group compared with controls (␤ ϭ 0.95; P ϭ .09; Table 3 ). Adjustment for change in body fat (total study population) did not change the association (Table 4) . Additionally, a change in body fat was not significantly associated with a change in SHBG levels (Table 5) .
DISCUSSION
Overall, the exercise intervention of the SHAPE study did not result in favorable effects on sex hormone levels in sedentary, postmenopausal women. Among women who lost more than 2% body fat, declines in all estrogens were not significantly different between exercisers and controls. Androgen levels decreased significantly in the exercise group who lost body fat compared with their peers in the control group. Furthermore, this study confirmed that fat loss was significantly associated with declines in postmenopausal estrogen levels. Although not significant, a similar trend was observed for the androgens. This study is the second intervention study assessing the effects of exercise on sex hormone levels in sedentary postmenopausal women. The first study of McTiernan et al 33, 34 reported the effects of a 12-month moderate-intensity exercise intervention on sex hormones among 173 sedentary, overweight, postmenopausal women. In contrast to our study, that study did observe significant declines in serum estrogens in exercisers compared with controls, but only in women who lost more than 2% body fat. The decline in estrogen levels in the intervention group of that study compared with ours was even slightly smaller, but they observed no declines in the control group, whereas we did. This might partly be explained by the fact that control women, despite our request to maintain their usual lifestyle pattern, decreased energy intake and became (slightly) more physically active (Hertogh et al, submitted for publication). However, the contrast in exercise level between the intervention and control groups at the end of our study was still substantial. Another difference was the inclusion of overweight and obese women (mean BMI, 30.5 kg/m 2 ) in the study by McTiernan et al, 33,34 whereas we included women with a BMI between 22 and 40 kg/m 2 (mean BMI, 27.0 kg/m 2 ). Overweight women have more fat mass and, therefore, higher levels of estrogens and more potential for improvement. Body fat loss in the study by McTiernan et al was also larger than in the SHAPE study (Ϫ1.4 v Ϫ0.81 kg, respectively). Furthermore, lack of an intervention effect might be explained by the amount of exercise. Women in the study by McTiernan et al were asked to exercise 3.75 hours a week compared with 2.5 hours in the SHAPE study. However, the intensity level of the SHAPE exercise program was higher, which might compensate for the shorter duration.
Interestingly, effects on androgen levels were similar; there was no effect in the total intervention group but a significant decline for testosterone in women who lost more than 2% of body fat.
33 Also for androstenedione, both studies showed the same trend in favor of the exercise group among women who lost body fat, although the difference between exercise and control groups was not significant in the study by McTiernan et al. 33, 34 The results of the subgroup analysis among women who lost body fat should be considered with caution because it is a post hoc analysis. A further limitation is that we deviated from protocol by not presenting the results on abdominal fat measured by ultrasound because this measure seemed to be not valid. We expected the measurement error to be larger than the anticipated differences. Furthermore, the aim of the SHAPE study was to assess the effect of exercise on hormone levels and not to establish weight loss. However, we cannot rule out that women participated in our study with the aim to lose weight. If so, this might explain the larger decrease in energy intake among women allocated to the control group (Ϫ445 kJ/d) compared with women in the intervention group (Ϫ27 kJ/d). Adjustment for energy intake did not change the results. Mean daily alcohol intake also decreased but in the same amount in intervention and control women (Ϫ1.3 and Ϫ1.4 g, respectively). Use of medication was low and not different between groups (data not shown).
Strengths of this study include the relatively large study population with a compliance rate comparable to other exercise intervention trials in older adults. 35 The combined aerobic and strength training comprised an exercise level achievable by postmenopausal women. The contrast in the level of physical activity after 12 months was substantial between the intervention and control groups. Furthermore, comprehensive measurement of body composition with dualenergy x-ray absorptiometry allowed us to address the effect of hormone changes in relation to body fat.
In conclusion, the exercise intervention in the SHAPE study did not result in significant decreases in serum estrogens and androgens in sedentary, postmenopausal women. Androgen levels were significantly more decreased in exercisers than in controls only in a subgroup of women who lost more than 2% body fat. Furthermore, this study confirmed that fat loss is associated with changes in postmenopausal sex hormone levels.
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‫ء‬
Generalized estimating equation analysis with two measurements of change (⌬ baseline and 4 months and ⌬ 4 and 12 months) of both independent and dependent variable. The ␤ is the coefficient of change in hormone level per unit (%) change in percent body fat (eg, as mean percent body fat increases by 1 unit the mean estrone level increases by 1.01 pg/mL).
